使用连续的初级和瘤逃生选择性瘤病毒的陷和伏击疗法
Mason J Webb1,2, Timothy Kottke2, Benjamin L Kendall2
1Division of Hematology/Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Molecular therapy oncolytics
|June 14, 2023
概括
序列性瘤性病毒传递可以治愈通常逃避治疗的瘤. 这种方法主要针对抗瘤T细胞反应,为复发性癌症提供了一种新的病毒免疫治疗策略.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫疗法癌症免疫疗法
- 瘤免疫学 瘤免疫学
背景情况:
- 瘤溶解性病毒疗法往往导致瘤早期反应和随后的复发.
- 像VSV-IFN-β这样的瘤病毒可以诱导突变 (例如,在CSDE1),促进瘤逃逸.
- 特定的突变,如CSDE1基因中的突变,是病毒治疗后瘤逃脱的关键驱动因素.
研究的目的:
- 研究利用瘤逃生突变进行增强型瘤治疗病毒疗法.
- 为了证明序列性瘤性病毒输送对逃脱瘤的疗效.
- 探索将病毒疗法与免疫检查点封锁相结合,以改善抗瘤免疫力.
主要方法:
- 两个不同的瘤性VSV的连续*in vivo*给药.
- 对瘤细胞突变的分析,包括特定的CSDE1点突变.
- 对抗瘤T细胞反应的评估和与CD200AR-L的联合治疗.
主要成果:
- 顺序的VSV输送成功地治愈了那些否则会逃避VSV-IFN-β治疗的瘤.
- 该策略有效地准了含有逃生促进CSDE1突变的瘤细胞.
- 治疗启动了强大的抗瘤T细胞反应,与免疫检查点阻塞协同作用.
结论:
- 通过顺序病毒疗法利用病毒逃生机制提供了一个强大的抗癌策略.
- 这种方法可以克服瘤对标准瘤解毒性病毒疗法的抗性.
- 开发向性病毒免疫疗法对治疗复发性和耐治疗性癌症具有前景.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines
434
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
434


